home All News open_in_new Full Article

Virus Respiratorio sinciziale (Vrs): in Italia ricoveri ridotti del 71% grazie al nuovo anticorpo Nirsevimab

Virus Respiratorio sinciziale (Vrs): in Italia ricoveri ridotti del 71% grazie al nuovo anticorpo Nirsevimab  Panorama della Sanità


today 19 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 2738481986
Add Watch Country

arrow_drop_down